Shifting consumer preferences towards self-medication is propelling the growth of the counter drugs market
Over-the-counter drugs
are drugs sold directly to a customer without a need for a doctor's
prescription, rather than a pharmacy, as opposed to over-the-counter
medication, which can be supplied only to medical users possessing a valid
prescription. There are various types of over-the-counter medication to aid in
the treatment of a number of different health ailments and conditions. Commonly
prescribed medications that are sold without prescriptions include cold
remedies, pain relievers, antihistamines, contraceptive pills, and cancer
medications. Over-the-counter drugs act as a temporary means to relieve pain,
provide relief for individuals who are experiencing a cold or flu and can
assist individuals with allergies and other health conditions.
The growing tendency
of self-medication is predominantly fueling the growth of the over-the-counter
Drugs market. According to the Med J DY Patil Vidyapeeth studies, India showed
the prevalence of self-medication as 37% in urban areas and 17% in rural areas
in India. 90 (38.1%) subjects felt confident that they were competent enough in
treating common ailments using self-medication. Additionally, growing rates of
patent expiration are shifting preferences of companies from Rx to OTC as a
counter-strategy. This is again expected to augment the growth of the over-the-counter
drugs market.
From the geographical
point of view, North America is expected to gain significant growth over the
forecast period, and this high preferences for over-the-counter drugs.
According to the Consumer Healthcare Products Association, 96 percent of U.S.
adults believe OTC medicines make it easy for individuals to care for minor medical
ailments. The availability of OTC medicines creates significant value for the
U.S. healthcare system: $146 billion in annual savings relative to
alternatives. On average, U.S. households spend about $338 per year on OTC
products.
Key Developments:
- In September 2020, Hamdard
Laboratories has launched six new over-the-counter (OTC) products to treat
common illnesses like colds and coughs. In September 2020, Dr. Reddy's
Laboratories has launched an over-the-counter (OTC) eye allergy drop
Olopatadine Hydrochloride Ophthalmic Solution in the US market.
- In September 2020, Genexa has
contributed to the expansion of the over-the-counter (OTC) industry with
the launch of its first-to-market clean medicine line for kids and adults.
- In January 2021, Hamdard Laboratories
has launched 12 Over Counter (OTC) medicines to boost immunity. The new
range of products contains ingredients like Aswagandhi, Kalonji, Gilo, and
Jamun powder along with Zafran which are known for strengthening body
immunity and overall health, Hamdard Laboratories said in a statement.
Comments
Post a Comment